BioPhase 8800 system

The BioPhase 8800 system continues to evolve alongside modern biopharmaceutical development.

At CE Pharm 2026, SCIEX announced new features added to the BioPhase 8800 system. These new capabilities are designed to support automation-enabled development workflows, configurable user management, expanded analytical sensitivity, and emerging modality applications.

Explore the expanded capabilities of the BioPhase 8800 system with technical resources and expert webinars.

Explore the capabilities of the BioPhase 8800 system

BioPhase software 1.6
Flexibility when you need it. Controls when they matter.

Early-stage development often prioritizes speed and flexibility, while later-stage projects may require greater oversight, documentation, and review processes. BioPhase software 1.6 allows teams to align user controls to project requirements without introducing unnecessary complexity.

BioPhase Instrument API
Scale development without adding complexity.

As pipelines move faster, laboratories need workflows that can scale without losing consistency. The BioPhase Instrument API enables integration of the BioPhase 8800 system with existing laboratory automation platforms, helping development teams connect SCIEX CE into broader automated workflows while maintaining visibility and control.

Native fluorescence detection
Expand analytical sensitivity and improve detection of low-level species in CE-SDS and cIEF workflows.

Oligo 200 nt Purity and Integrity kit
Single-nucleotide resolution for oligonucleotides, ready to go when you are. Designed for analytical development and quality control in genomic medicine workflows, the Oligo 200 nt Purity and Integrity kit supports high-resolution characterization of mRNA poly(A) tail length distributions and more.